Rakesh Jhunjhunwala’s net worth surges by over Rs 10000 cr QoQ; Star Health, Metro Brands stocks instrumental in billionaire investor's rise in fortunes

Billionaire investor Rakesh Jhunjhunwala has added over Rs 10000 crore in his net worth sequentially through his stock portfolio as of January 27, 2022, according to data from terndlyne.com.  In September quarter, the celebrity investor had a net worth of Rs 23,535.0 crore, the data revealed.  

The drastic surge in his fortunes was on the back of listing of two companies – Star Health and Allied Insurance and Metro Brands. He holds promoter stake of 17.5 and 14.4 per cent respectively in both the companies along with his wife Rekha Jhunjhunwala.  

See Zee Business Live TV Streaming Below:

Rakesh Jhunjhunwala along with his wife Rekha Jhunjhunwala and associates hold 37 stocks with a net worth of over Rs 34,160.4 crore as per corporate shareholdings filed for December quarter, trendlyne.com revealed.  

The ace investor has bought some extra shares in two Tata Group heavyweights – Titan Company and Tata Motors by 0.2 and 0.1 per cent respectively. In addition, he also bought 0.1 per cent extra stakes in another Tata Group-backed entity Indian Hotels Company. 

On the contrary, the investor has slashed around 1 per cent stakes in chemical company Jubilant Ingrevia, gaming firm Nazara Technologies and PSU metal company SAIL in December quarter. 

He has also reduced 0.6 per cent shares in TV18 Broadcast and 0.3 per cent in Aptech, in which he holds promoter stakes during the December quarter, as per the companies’ shareholding pattern.   

The investors’ holding Prakash Pipes, Prakash Industries, The Mandhana Retail and TARC has gone below 1 per cent, as per the latest shareholding pattern of these companies available on the BSE.  

Rakesh Jhunjhunwala, who is also called as the Big Bull of the Indian stock market, has stayed put in at least couple of dozens’ companies in his portfolio. The ace investor also manages the asset firm Rare Enterprises and tends to favor stocks in the finance, tech, retail and pharma sectors.